Name: Fisher & Paykel Healthcare (FPH) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

FPH

Health Care Equipment & Services

Fisher & Paykel Healthcare

Short interest: 0.04%; −0.09 pp 30d; as of 8 Oct 2026
Reported shorts: 263.1K
Shares on issue: 588.265M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer, and marketer of medical devices and systems for respiratory care, acute care, surgery, and the treatment of obstructive sleep apnea. The company's products are sold in over 120 countries, focusing on improving patient care and outcomes through innovative healthcare solutions and a commitment to 'Care by Design'.

Company profile →

Fisher & Paykel Healthcare (ASX:FPH) has 0.04% of its shares on issue reported as short positions as of 8 Oct 2026, or about 263,089 shares. Over the past 30 days that figure has fallen 0.09 percentage points, and over 90 days it has fallen 0.15 percentage points. Its highest recorded short interest was 1.28% in June 2018. FPH is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads FPH today

Zanger BreakoutWatchScore 41rank 217 of 1942
CAN SLIMWatchScore 53rank 30 of 1541
Minervini Trend TemplateWatchScore 61rank 186 of 1716
Crowded-Short BreakoutWatchScore 23rank 238 of 1502
Quality compoundersTriggeredScore 87rank 6 of 1669

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

FPH fundamentals

In the year to 31 Mar 2026, Fisher & Paykel Healthcare (ASX:FPH) recorded revenue of NZ$2.3B and net profit after tax of NZ$468.5M. A year earlier it recorded revenue of NZ$1.3B and net profit after tax of NZ$377.2M. Year-on-year growth: revenue +80.3% (FY), EPS +24.1% (TTM). Net margin 20.3%, return on equity 23.4% (FY). Figures are in NZD, the company's reporting currency; source: Yahoo Finance, as at 9 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →